CSPG4 and cutaneous melanoma: Furthermore, to study the potential of CSPG4 IgE to restrict patient-derived melanoma growth, mice were transplanted with patient-derived cutaneous melanoma tumor xenografts (PDX) from two individuals with stage III and IV cutaneous melanoma metastases and engrafted with autologous peripheral blood lymphocytes (PBLs) from the same patients.